TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
Ann Rita Halvorsen(Oslo University Hospital), Åslaug Helland(Oslo University Hospital)
Cited by 120
Related Papers
Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
|Cell Reports|2014|283
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
|PLoS ONE|2011|219
Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis
|Genome biology|2014|179
Intratumor heterogeneity defines treatment‐resistant <scp>HER</scp> 2+ breast tumors
|Molecular Oncology|2018|102
The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery
|Molecular Oncology|2019|94